Latest Breaking News On - மகிழ்ச்சி வாழ்க்கை அறிவியல் - Page 12 : vimarsana.com
Remedesvir hoarders won t be spared, says K taka Home Minister
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
Centre orders diversion of Remdesivir stocks to four States
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
India s new COVID-19 cases hit record again amid vaccination push
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Growing Uptake in Cancer Diagnostics and Therapeutics Open New Frontiers in Radiopharmaceutical Market, Valuation Predicted to Touch ~US$ 5.4 Bn by 2027, TMR
Increasing deployment of
99m Tc Isotope in disease diagnostic and other emerging applications of nuclear medicine to thrive on multi-disciplinary research
-
Players aim at complying with stringent regulatory guidelines to develop new radiopharmaceuticals
ALBANY, N.Y., April 14, 2021 /PRNewswire/ The use of radiopharmaceuticals as a therapeutic modality is gaining traction in neurology, oncology, and cardiology. The expanding array of radiopharmaceutical agents is enriching the arena of radiopharmaceutical therapy and advancing its use in metastatic cancer. The growing number of radiopharmaceuticals approved for therapy by the FDA is a key trend expanding the frontiers in radiopharmaceuticals market. The therapies show the combined efficacy of chemotherapy and targeted biologic therapy. The expanding avenue of nuclear m
NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained.
As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management.
How did Remdesivir come into use?
Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease.